Table 2.
Gene | Datasets * | Direction | Reported Expression and Function | ||
---|---|---|---|---|---|
K | S | B | |||
Chemokines Bind Chemokine Receptors | |||||
CXCL8 | ↑CMM | Protein expression increased in CMM vs. nevi by IHC [28,29] | |||
Promotes melanoma progression and metastasis [33,34,35] | |||||
CXCL9
CXCL10 |
↑CMM | CXCL9 and CXCL10 increased gene expression in CMM vs. BN by qRT-PCR [30] | |||
CXCL9 and CXCL10 in gene signature that differentiates BN and CMM [55,56,57] | |||||
CXCL9 increased gene expression in melanoma metastases vs. BN [58] | |||||
CXCL9 and CXCL10 recruits CXCR3-expressing effector T cells and natural killer cells into melanoma [59] | |||||
CXCL10 binds CXCR3 on tumor cells to promote metastases [36] | |||||
CCL27 | ↓CMM | Recruits T cells in melanoma mouse model [32] | |||
Peptide Ligand-Binding Receptors | |||||
C3AR1 | ↑CMM | Increases melanoma tumor growth by inhibiting neutrophil and CD4+ T cell responses [31] | |||
IL-4 and IL-13 Signaling Pathways | |||||
GATA3 | ↓CMM | Stabilizes HIF-1α to enhance cancer invasiveness under hypoxic conditions [60] | |||
MMP3 | ↑CMM | Protein expressed in CMM lesions, but not normal skin, by IHC and IF [61] | |||
Promotes melanoma tumor growth and metastasis [37] | |||||
MMP13 | ↑CMM | Protein expression in some CMM cases, absent in BN, by IHC [62] | |||
VIM | ↓CMM | Protein uniformly expressed in BN and CMM melanocytes by IF [63] | |||
Cytokine Signaling | |||||
GZMB | ↑CMM | Increased GZMB-expressing cells in DN (severe atypia) and CMM vs. BN and DN (mild atypia) by IHC [42] | |||
FCGR1B | ↑CMM | Induced by interferon-γ [64,65] | |||
GBP5 | ↑CMM | Induced by interferon-γ and type 1 interferons | |||
Stimulates assembly of NLRP3 inflammasome [39], which expands myeloid-derived suppressor cells in melanoma leading to immunosuppression and increased tumor growth [40] | |||||
KPNA2 | ↑CMM | Promotes proliferation, migration, and invasion in melanoma cells [38,41] | |||
OAS2 | ↑CMM | Induced by type 1 interferons and important in anti-viral immune response | |||
Gene expression induced by UVB in human primary melanocytes (qRT-PCR) [66] | |||||
Metal Sequestration by Antimicrobial Peptides | |||||
S100A7
S100A8 S100A9 |
↑CMM | S100A7, S100A8, and S100A9 increased gene expression in CMM vs. BN by qRT-PCR [55,56,57] | |||
S100A7, S100A8, and S100A9 in gene signature that differentiates BN and CMM [55,56,57] | |||||
S100A7, S100A8, and S100A9 linked to tumor growth and metastasis in multiple cancers [43] | |||||
S100A9 promotes migration and metastasis of EMMPRIN-expressing melanoma cells [44] | |||||
Immune System | |||||
AIM2 | ↑CMM | Expression in dendritic cells promotes immunosuppressive tumor microenvironment and increased melanoma tumor growth [45] | |||
ASB11 | ↓CMM | Downregulated by DNA damage, stabilizes pro-apoptotic protein BIK, which increases apoptosis [67] | |||
C1QA | ↑CMM | C1q protein (composed of C1QA, C1QB, and C1QC) expressed by mesenchymal cells and immune cells in melanoma by IHC [46] C1qa-/- mice have slower melanoma tumor growth, prolonged survival, decreased tumor angiogenesis, and decreased lung metastasis [46] C1q from non-bone marrow-derived cells promotes accelerated melanoma tumor growth [46] C1q promotes cell adhesion, migration, and proliferation of melanoma cells [46] |
|||
C1QB | ↑CMM | ||||
DFNA5/
GSDME |
↑CMM | Gene expression increased in CMM vs. normal skin by RNAseq [68] | |||
Included in pyroptosis-related gene signature for BN vs. CMM [68] | |||||
Triggers pyroptosis and apoptosis [47] | |||||
Deficiency in melanoma cells increases in vitro and in vivo tumor growth [47] | |||||
CHIT1 | ↑CMM | Produced by macrophages stimulated by interferon-γ and tumor necrosis factor-α [69] | |||
Increases transforming growth factor-β SMAD signaling [69], which plays role in melanoma metastasis [70] and angiogenesis in various cancers [71] | |||||
CTSB | ↑CMM | Involved in metastasis [72,73], angiogenesis, and invasion of tumor cells, including melanoma [74,75,76] | |||
FCGR3A | ↑CMM | Expressed on subset of natural killer cells [77] Mediates antibody-dependent cell-mediated cytotoxicity [77] |
|||
GLA | ↓CMM | Patients with GLA deficiency possibly have increased rate of melanoma [78] | |||
KLRD1 | ↑CMM | Protein expressed on tumor infiltrating lymphocytes in CMM by IHC [79] | |||
Regulates natural killer cell cytotoxicity [79] | |||||
PYGL | ↓CMM | Differentially expressed in BN with and without V600E BRAF mutation by microarray [80] | |||
Involved in glycogen metabolism, which regulates inflammatory responses and tumorigenesis [81,82,83] | |||||
RNF182 | ↑CMM | Suppresses Toll-like receptor-triggered immune response and decreases production of proinflammatory cytokines [84] | |||
TREM2 | ↑CMM | Encodes for innate immune receptor on tumor infiltrating myeloid cells [85] | |||
TREM2 deletion decreases immunosuppressive regulatory myeloid cells within tumors, which decreases exhausted CD8+ T cell subsets and tumor growth [86] | |||||
Regulation of Insulin-like Growth Factor Transport and Uptake by Insulin-like Growth Factor Binding Proteins | |||||
IGFBP4 | ↑CMM | Protein expressed in CMM by IHC [87] | |||
IGFBP5 | ↓CMM | Gene and protein expression increased in CMM vs. nevi by qRT-PCR and IHC [48] | |||
Gene expression increased in metastatic melanoma vs. BN by RNAseq [58] | |||||
Overexpression inhibits in vitro proliferation, migration, invasion, epithelial to mesenchymal transition, and in vivo tumor growth and metastasis of melanoma cell lines [48] | |||||
PRSS23 | ↑CMM | Knockdown decreases cancer cell proliferation in breast and gastric cancer [49,50] | |||
SCG2 | ↑CMM | Gene expression increased in VGM and metastatic melanoma vs. normal skin, BN, and melanoma in situ by microarray [27] | |||
Increases migration of melanoma cells [52] | |||||
Plays role in chemoattraction and migration [51] | |||||
SPP1 | ↑CMM | Increased expression in CMM vs. BN across 5 studies (RNAseq, microarray, IHC) [58,88,89,90,91] | |||
Included in 5 protein assay that distinguishes BN vs. CMM by IHC [89] | |||||
SPP1 treatment increases melanoma cell migration, invasion, and proliferation [54] | |||||
SPP1 knockdown decreased in vitro and in vivo proliferation, migration, and invasion of melanoma cells [53] |
* K, Krueger; S, Scatolini; B, Bastian; IF, immunofluorescence; IHC, immunohistochemistry; qRT-PCR, quantitative reverse transcription polymerase chain reaction; RNAseq, RNA sequencing.